Arsenic drug combo resurrects 'guardian of the genome' to fight aggressive blood cancers
A combination cancer therapy that relies on the reactivation of a tumor suppressor protein to kill leukemic and other blood cancer cells has shown promise in a small pilot trial.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Unifying mechanism explains how common cancer mutations fuel growth
Science
Biology
United States
-
How the heart's unusual carbohydrate metabolism helps it stay strong
Science
Biology
United States
-
Who uses nicotine pouches?
Health
Public Health
United States
-
Brain scans challenge link between prefrontal activity and ability to regulate emotions
Science
Research
Global
-
Three studies reveal the hidden layers between DNA and disease
Science
Biology
Australia
-
Abnormal neurons are surprisingly common in the developing brain
Science
Biology
United States
-
The 13 Best Cleansers for Mature Skin, According to Dermatologists
Culture & Lifestyle
Home & DIY
-
Global stroke burden keeps rising despite falling stroke rates
Health
Public Health
Global